Zwicker and Xu reported that IL-34 might inhibit TNF-α expression in macrophages 1 and overlap with the anti-inflammatory cytokine IL-10-secreting macrophages in inflammatory bowel disease and infectious disease models, suggesting the anti-inflammatory potential of IL-34 [23, 24]. Here, IL10 is linked to inflammatory bowel disease.